Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 10659
  • 10660
  • 10661
  • …
  • ›
  • »

2025-05-13

BlueLinx Appoints Christopher Kelly Wall as SVP, Chief Financial Officer and Treasurer

2025-05-13

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update

2025-05-13

CarParts GAAP EPS of -$0.27 misses by $0.09, revenue of $147.38M beats by $1.24M

2025-05-13

Spero Therapeutics GAAP EPS of -$0.25 beats by $0.30, revenue of $5.87M

2025-05-13

CarParts.com Reports First Quarter 2025 Results

2025-05-13

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

2025-05-13

Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

2025-05-13

CVD Equipment Corporation Reports First Quarter 2025 Financial Results

2025-05-13

GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025

2025-05-13

IZEA Announces Intention to Commence a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock

2025-05-13

IZEA Reports Q1 2025 Revenue from Core Operations of $8.0 million, up 23%

2025-05-13

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

  • «
  • ‹
  • …
  • 10659
  • 10660
  • 10661
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies